You just read:

Resverlogix Highlights Unique Properties of Apabetalone in Both a Rare Muscular Dystrophy (FSHD) and Neurodegenerative Eye Disease

News provided by

Resverlogix Corp.

13 Feb, 2017, 07:00 ET